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Abstract
Background Shared decision-making (SDM) is the
process in which healthcare professionals and
patients jointly discuss and decide which care and
treatment policy is to be followed. The importance of
SDM is increasingly being recognised across
health settings, including palliative care. Little is
known about SDM with people with intellectual
disabilities (IDs) in the last phase of life. This
review aimed to explore to which extent and in
which way people with ID in the last phase of life are
involved in decision-making about their care and
treatment.
Method In this scoping review, we systematically
searched in the Embase, Medline and PsycINFO
databases for empirical studies on decision-making
with people with ID in the last phase of life.
Results Of a total of 281 identified titles and
abstracts, 10 studies fulfilled the inclusion criteria. All
focused on medical end-of-life decisions, such as
foregoing life-sustaining treatment,
do-not-attempt-resuscitation orders or palliative se-
dation. All studies emphasise the relevance of involv-
ing people with ID themselves, or at least their
relatives, in making decisions at the end of life. Still,
only two papers described processes of
decision-making in which persons with ID actively
participated. Furthermore, in only one paper, best
practices and guidelines for decision-making in
palliative care for people with ID were defined.
Conclusion Although the importance of involving
people with ID in the decision-making process is
emphasised, best practices or guidelines about what
this should look like are lacking. We recommend
developing aids that specifically support SDM with
people with ID in the last phase of life.
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Introduction
In palliative care, the emphasis on shared
decision-making (SDM), i.e. decision-making by
healthcare professionals and patients (Charles
et al. 1997) is growing. Palliative care is ‘an approach
that improves quality of life of people with life limiting
conditions due to illness and frailty and their families’
(World Health Organisation n.d.). Timely
recognition of the palliative phase is key to allow
discussion of preferences and to apply these in
provided care (Vrijmoeth et al. 2016a; Vrijmoeth
et al. 2016b). A structured approach may provide
support in these SDM processes.
The concept of SDM first appeared in literature in
1997 (Charles et al. 1997). Through SDM patients
can be included in decision-making when multiple
treatment options coexist (Stiggelbout et al. 2015).
Ideally, healthcare professionals clearly explain
relevant care or treatment options and support
patients in weighing their preferences and values in
the context of these options before a treatment
decision is made (Stiggelbout et al. 2012). A
systematic review showed that patients who
participated in SDM tended to report positive
outcomes, such as a higher degree of patient
satisfaction and less decisional conflict (Shay and
Lafata 2015). SDM is often mentioned in the context
of medical treatment but is also applicable in
non-medical care and support, such as adjusting
daytime activities and hobbies (Stiggelbout
et al. 2015). So far, SDM models have not specifically
described their use by people with intellectual
disabilities (IDs) (Charles et al. 1999; Towle and
Godolphin 1999; Makoul and Clayman 2006; Elwyn
et al. 2012).
The relevance of involvement of people with ID in
SDM might be obvious. However, in practice,
assessing preferences and values of people with ID
can be hindered by their ID or co-morbid conditions.
Involvement of close proxies may be required. Other
barriers for SDM include negative attitudes and lack
of knowledge and skills in healthcare professionals
(Stiggelbout et al. 2015). In addition, it can be difficult
for people with ID to weigh the different options and
to oversee their consequences in the longer term.
People with ID may not always comprehend the
information about and implications of their illness,
which limits their decision-making capacity
(Tuffrey-Wijne 2013; Szmukler 2019).
In spite of limited or absent decision-making
capacity, people’s preferences have to be taken into
account. Article 12 recognises the right of people with
ID to (United Nations 2006) be recognised by law as
a person equal to others (United Nations 2006).
People with ID have the right to be supported in
making choices even if they cannot make such
decisions by themselves (Szmukler 2019). See Box 1
for an example.
Knowledge about how to engage people with ID in
decision-making in the last phase of life is limited, and
research is still scarce. This review aimed to explore in
which way people with ID in the last phase of life are
involved in decision-making about their care and
treatment.
Methods
Design
Given the exploratory nature of this study we opted
for a scoping review. This is defined as: ‘a form of
knowledge synthesis that addresses an exploratory
research question aimed at mapping key concepts,
types of evidence and gaps in research related to a
defined area or field by systematically searching,
selecting and synthesizing existing knowledge’
(Colquhoun et al. 2014). We followed the PRISMA
Scoping Review Guidelines (Tricco et al. 2018).
(Appendix A). In collaboration with a biomedical
information specialist, we systematically searched the
electronic databases Embase, Medline and
PsycINFO in October 2018 and updated the search in
September 2019. We used relevant search terms and
synonyms related to ID, SDM and palliative care (see
Box 2 for the Embase search protocol).
We used the following inclusion criteria: (1) study
with or about people with ID in the last phase of life;
(2) occurrence of elements of decision-making in
practice in experimental or observational studies; (3)
peer-reviewed journal and (4) written in English. We
applied no limits on date of publication. We excluded
editorials, letters and conference reports and checked
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systematic reviews and meta-analyses for useful
references.
Procedure
Two researchers (HN and IK) independently
screened titles and abstracts. Disagreements about
study inclusion were resolved by discussion by HN,
IK and ME. They developed, reviewed and approved
a data extraction form containing title, country, study
aim, study design, described decisions and
involvement of people with ID in the process of
decision-making. HN and ME pilot tested this form
by independently extracting data from one study and
comparing their results. Changes to the data
extraction form were not required. Using this form,
HN and ME independently extracted data from the
remaining studies.
Aiming at high inter-rater agreement, HN, IK and
ME discussed the results to identify elements of
decision-making and possible differences in the
interpretation of these elements. To evaluate,
3
Box 1. An example of decisions in the context of a person with ID.
Box 2. Complete Embase search string.
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structure and describe processes of decision-making
as identified in this review, we looked for a suitable
SDM framework. We opted for the SDM model of
van de Pol et al. (2016) because it is aimed at frail
patients with multimorbidity, in the context of a
continuous SDM process and takes into account the
involvement of relatives. van de Pols model
distinguishes six steps (Box 3). In brief, these steps are
(1) Preparation (history; problem analysis); (2) Goal
talk (identify discussion partner; identify patient
values and goals of care); (3) Choice talk (summarise
and offer choice; patient formulates treatment aims);
(4) Option talk (personalised treatment aims are
discussed); (5) Decision talk (focus on preferences;
connect to the patients values; goals of care and
treatment aims; decide) and (6) Evaluation (evaluate
the SDM process; prepare a treatment plan).
Results
We found 281 articles. After the selection process, as
shown in Fig. 1, 10 studies were included for data
extraction.
4
Box 3. The six steps of van de Pol et al. (2016) SDM model.
Figure 1. Study flow diagram.
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Study characteristics
Of the 10 included studies, eight were conducted in
the Netherlands, one in Australia, and one in the
United States. Six studies were (semi-structured) in-
terview studies (Van Thiel et al. 1997; Wagemans
et al. 2013a; Wagemans et al. 2013b; Bekkema
et al. 2015; Zaal-Schuller et al. 2016; Zaal-Schuller
et al. 2018), two included multiple case studies
(Watson et al. 2017; Tuffrey-Wijne et al. 2018), one
was a single case study (Lohiya et al. 2003), and in one
study, medical files were examined (Wagemans
et al. 2010). All studies had an observational design.
The total number of participants across all studies
was 317, ranging from 1 to 89 per study and included
parents, physicians and people with ID. All studies
involved interviews with and examination of the role
of target groups. Five studies focused on healthcare
professionals and relatives of people with an ID
(Wagemans et al. 2010; Bekkema et al. 2015;
Zaal-Schuller et al. 2016; Watson et al. 2017;
Zaal-Schuller et al. 2018), four on healthcare
professionals (Van Thiel et al. 1997; Lohiya
et al. 2003; Wagemans et al. 2013a; Tuffrey-Wijne
et al. 2018) and one on relatives of people with an ID
(Wagemans et al. 2013b). Eight studies were
published within the last 10 years; the other two were
from 2003 and 1997.
All studies focused on end-of-life decision-making,
e.g. deciding about life-prolonging treatments. All
studies focused on adults with ID; four studies also
focused on children with ID (Wagemans et al. 2013b;
Bekkema et al. 2015; Zaal-Schuller et al. 2016;
Zaal-Schuller et al. 2018); six studies included people
with various levels of ID (Van Thiel et al. 1997;
Wagemans et al. 2010; Wagemans et al. 2013a;
Wagemans et al. 2013b; Bekkema et al. 2015; Watson
et al. 2017), two studies focused on people with
profound ID (Zaal-Schuller et al. 2016; Zaal-Schuller
et al. 2018), one involved people with mild ID
(Tuffrey-Wijne et al. 2018) and one people with
moderate ID (Lohiya et al. 2003).
In four studies, people with ID received residential
care (Van Thiel et al. 1997; Lohiya et al. 2003;
Wagemans et al. 2010; Wagemans et al. 2013a), in
four other studies, they received residential and
community-based care (Wagemans et al. 2013b;
Bekkema et al. 2015; Watson et al. 2017;
Tuffrey-Wijne et al. 2018), and for two studies, this
was not specified (Zaal-Schuller et al. 2016;
Zaal-Schuller et al. 2018), see Table 1 for an overview.
Preparation: history and problem analysis
Life history of the person with intellectual disability. Five
articles included a description of how the life history
of the person with ID was taken into account in the
decision-making process (Van Thiel et al. 1997;
Wagemans et al. 2013b; Bekkema et al. 2015;
Zaal-Schuller et al. 2016; Watson et al. 2017). In two
studies, life stories helped to provide information
about people’s preferences considering health and
treatment (Wagemans et al. 2013b; Watson
et al. 2017). In one study, the views of parents and
physicians on the quality of life of people with ID were
reported to differ (Zaal-Schuller et al. 2018).
Problem analysis. In one study, the experiences of 17
parents of children with profound multiple and
intellectual disabilities during
end-of-life-decision-making were reported
(Zaal-Schuller et al. 2016). These parents reported
they had to explain to physicians how their child was
feeling and, for example, when their child was in pain
(Zaal-Schuller et al. 2016). Parents mentioned to
prefer starting the end-of-life decision-making process
with a physician who already had a relationship with
their child and therefore could better analyse their
child’s problems. They believed that a physician who
is aware of the history of their child can provide better
treatment than a physician without that awareness
(Zaal-Schuller et al. 2016).
Goal talk: identify discussion partner and identify patient
values and goals of care
All articles emphasised that the extent to which
people with ID may be partners in the
decision-making process is dependent upon their
capacity to make difficult choices. In her description
of the participation of people with ID in
decision-making processes about euthanasia and
assisted suicide requests, Tuffrey-Wijne et al. (2018)
noted two aspects that are difficult for people with ID:
appreciating the significance of the information and
weighing of treatment options and their
consequences. In eight identified studies, people with
ID did not participate in the decision-making process.
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In one study, a case is described in which care
professionals thought it was better to tell a woman
with ID she had reached the last phase of life, whereas
her family did not want to inform her, to protect her
from distress (Wagemans et al. 2010).
Two studies described the involvement of people
with ID in the decision-making process. In the
described euthanasia and suicide requests study from
Tuffrey-Wijne et al. (2018), each case report included
the statement ‘the physician had sufficiently informed
the patient about his/her situation and his/her
prospects’. The authors noted that there is no
information about how the people with ID were
helped to understand this information (Tuffrey-Wijne
et al. 2018). In another study, it was stated that two
people with ID were involved in the decision-making
process but it was not specified how (Van Thiel
et al. 1997). In five studies, it was not clear how the
signals, values and goals of care of people with ID
were weighted in the decision-making process (Van
Thiel et al. 1997; Lohiya et al. 2003; Wagemans
et al. 2013a; Wagemans et al. 2013b; Tuffrey-Wijne
et al. 2018).
Seven studies stated the importance of including
the people who care for and about a person with ID in
the decision-making process (Van Thiel et al. 1997;
Wagemans et al. 2013a; Wagemans et al. 2013b;
Bekkema et al. 2015; Watson et al. 2017;
Tuffrey-Wijne et al. 2018; Zaal-Schuller et al. 2018).
Judicial regulations around decision-making for
people with ID who lack capacity vary. In the
Netherlands (where most studies were based), par-
ents or other legal representatives have to make deci-
sions for persons with ID who lack decision-making
capacity, although a physician remains ultimately re-
sponsible for the medical care as provided (Van Thiel
et al. 1997; Lohiya et al. 2003; Wagemans et al. 2010;
Wagemans et al. 2013a; Wagemans et al. 2013b;
Zaal-Schuller et al. 2016; Zaal-Schuller et al. 2018).
Watson et al. (2017) stated that to properly represent
the interests of a person with severe to profound ID
an emotionally involved support network is needed.
They developed a continuum of so-called relational
closeness tools that can be used to find out who is
close to a person with severe or profound ID (Watson
et al. 2017). To support such networks, they devel-
oped a supported decision-making framework (Wat-
son et al. 2017). They characterise supported
decision-making ‘as a process of enhancing the
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decision-making capability of people with severe or
profound intellectual disability through collaborative
support from a group of people in the relevant per-
son’s life who know them. An important component
of this approach is the use of a circle of support, a
group of key members of the concerned person’s life
who have a good understanding (or are committed to
developing one) of the person’s life history, personal
characteristics and their preferences)’(Watson 2016).
Choice talk: summarise, offer choice and patient
formulates treatment aims
In two studies, people with ID were informed about
their situation and their prospects (Van Thiel
et al. 1997; Tuffrey-Wijne et al. 2018). In one study,
this was done by ‘sufficiently informing her at her own
level’(Tuffrey-Wijne et al. 2018). In another study,
this process remained unclear (Van Thiel et al. 1997).
In the eight other studies, patient representatives and
physicians formulated treatment aims without direct
involvement of people with ID (Lohiya et al. 2003;
Wagemans et al. 2010; Wagemans et al. 2013a;
Wagemans et al. 2013b; Bekkema et al. 2015;
Zaal-Schuller et al. 2016; Watson et al. 2017;
Zaal-Schuller et al. 2018).
Watson et al. (2017) described how available
treatment options for a person with a profound
disability were explored by a group of people who
knew him very well (Watson et al. 2017).
Zaal-Schuller et al. (2016) described how 17 parents
anticipated the recurrence of serious illness of their
children. ‘Almost half of them’ believed that it would
have been easier to discuss end-of-life decisions with
the physicians earlier, when their child was still in a
stable condition (Zaal-Schuller et al. 2016).
According to one study, parents and physicians
agreed about three elements being key to quality of
life of children with profound intellectual and
multiple disabilities: (1) the ability to enjoy
themselves, (2) the absence of physical problems and
(3) comfort (Zaal-Schuller et al. 2018). Some parents
thought that not all important aspects of quality of life
had been fully explored in discussions with care
professionals. Physicians, on the other hand, reported
they already knew parents’ views on quality of life and
were therefore not discussing it (Zaal-Schuller
et al. 2018). Another study described how instead of
parents, an ethics committee participated in choice
talk (Lohiya et al. 2003).
Option talk: personalised treatment aims are discussed
According to one study, physicians and parents
agreed that disagreements between physicians and
parents could ultimately improve the
end-of-life-decision-making process, because these
enabled the exploration of alternative treatments
(Zaal-Schuller et al. 2016). Another study, based on
nine interviews with ID physicians, stated that wishes
of relatives weighed heavily when discussing t
treatment options (Wagemans et al. 2013a). In eight
out of nine cases presented by Wagemans
et al. (2013a), physicians followed the relatives’ wishes
about treatment choice. Parents and physicians
indicated that if an invasive treatment was not
expected to lead to a significant improvement of the
child’s quality of life, they would rather withdraw or
withhold that treatment (Wagemans et al. 2013b;
Zaal-Schuller et al. 2018).
Lohiya et al. (2003) reported how difficult it is when
people with ID have never been able to express their
values or preferences (Lohiya et al. 2003). Watson
et al. (2017) explained that, in terms of roles, people
with ID express their preferences (e.g. by behaviour;
eye movement; vocalisation; self-harm or facial
expression), whereas the professionals or relatives
need to respond to these preferences by interpreting
and acknowledging them.
Decision talk: focus on preferences, based on the patients’
values, goals of care and treatment aims, decide
If people with ID were involved in decision-making
processes, it was not clear how the physician helped
them to understand their situation (Van Thiel
et al. 1997; Tuffrey-Wijne et al. 2018). In two studies,
people with ID were not involved in the
decision-making process because of their lack of
decisional competence (Wagemans et al. 2013a;
Zaal-Schuller et al. 2018).
In four studies, the difficulties patient
representatives may experience when having to decide
between various options, including feeling morally
responsible for end-of-life decisions they have to
make, were shown (Wagemans et al. 2010; Wagemans
et al. 2013a; Wagemans et al. 2013b; Bekkema
et al. 2015).
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Evaluate: evaluate the shared decision-making process
and prepare a treatment plan
In one study, when asked about the provision of
information, parents stated they felt a lack of
information during the end-of-life decision-making
process (Zaal-Schuller et al. 2016). When they were
provided with information they felt they lacked the
necessary medical background to put that information
in the right context. However, parents felt the
physician took them seriously as being experts about
their children and allowed them to influence the
decision-making process (Zaal-Schuller et al. 2016).
Based on 16 interviews with patient representatives,
Wagemans et al. (2013b) indicated that patient
representatives found support of a doctor very
important in the decision-making process. According
to Wagemans et al. (2013a) physicians sought
consensus with relatives and paid care staff. In this
process, physicians often gave greater weight to a
good relationship with relatives and paid care staff
than to their own assessment of the best interest of the
person with ID.
Discussion
This review is the first to provide an overview of how
decision-making with people with IDs in the last
phase of life is practiced. The results show us that
making decisions together with people with ID is not
common practice. We found that people with ID
participated in the decision-making process in only 2
out of 10 studies (Van Thiel et al. 1997; Tuffrey-Wijne
et al. 2018). Where people with ID participated, it was
largely unclear how this process was enabled and what
kind of support, if any, was provided to the people
with ID.
Most authors stated that relatives and care staff
know persons with ID best (Van Thiel et al. 1997;
Wagemans et al. 2013a; Wagemans et al. 2013b;
Bekkema et al. 2015; Watson et al. 2017;
Tuffrey-Wijne et al. 2018; Zaal-Schuller et al. 2018).
They know how to communicate with the person with
ID and how to interpret the signals they are giving
(Bekkema et al. 2015; Watson et al. 2017). By using
this information, it is possible to act on the
preferences of people with ID, even if they themselves
cannot articulate them clearly, and to make decisions
that match their wishes and preferences (Watson
et al. 2017). That is why good communication
between relatives and professionals is important
(Wagemans et al. 2013a; Bekkema et al. 2015;
Zaal-Schuller et al. 2016; Watson et al. 2017). Using
documentation such as videos and diaries can help to
match decisions with the preferences of people with
ID (Watson et al. 2017), even when they cannot
participate actively in the decision-making process, or
do not have sufficient decision-making capacity
(Watson et al. 2017).
The existing literature offers few good examples of
SDM models for people with ID. Based on Elwyn
et al. (2012) SDM model, van de Pol et al. (2016)
developed a model for SDM with frail older people.
This takes into account co-morbid conditions and
involvement of relatives and considers
decision-making as a process rather than a one-off
event. The model could provide a good basis for
SDM for people with ID. Van de Pol’s model does
not pay attention to eliciting values that are important
for the patient or how to address decision-making
capacity.
Watson et al. (2017) developed a supported
decision-making framework for people with ID. This
framework ensures that if people with ID are not able
to participate in the decision-making process
themselves, a key group around the person with ID
participates on behalf of them, keeping the values and
preferences of the person with ID in mind. Research
into best practices with regard to SDM in the last
phase of life shows some examples about other
vulnerable populations. One study focused on people
with dementia and their caregivers and the extent to
which housing decisions matched with an
interprofessional SDM approach (Garvelink
et al. 2018). This study indicated that honesty, timely
communication and advance care planning helped to
better align decisions with preferences of patients.
This research can potentially be used as a basis for the
development of an aid to support SDM in people with
ID in the last phase of life. The supported
decision-making model of (Watson et al. 2017) could
also be used as foundation to develop an SDMmodel
for people with an ID. New research could focus on
making this model suitable for people with ID with
different levels of participation abilities. For future
research, we would recommend that people with an
ID are involved in the development and
implementation of new approaches considering
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decision-making with people with an ID. The target
group itself can provide valuable input about what
does and does not work for them.
Implications for practice and research
Adequate SDM processes are underpinned by good
relationships between physicians and relatives and
care staff of people with ID (Wagemans et al. 2013a;
Bekkema et al. 2015; Zaal-Schuller et al. 2016; Watson
et al. 2017). Defining clear roles and responsibilities
for everybody involved could improve the process of
developing these relationships (Wagemans
et al. 2013b). When parents and care staff build a
strong relationship well before there is a crisis or a
need for important end-of-life decisions, they can
better collaborate as a team when death is
approaching (Bekkema et al. 2015). There is a need
for cooperation in building up a shared understanding
of the signals and needs of a person with ID. To make
a good decision, professionals and relatives should be
attentive to the expression and signals of need and
distress of the person with ID (Bekkema et al. 2015;
Watson et al. 2017). Support may be even more
necessary since people with ID may have limited
experience in making important decisions that will
affect their lives and may lack the necessary skills to
make end-of-life decisions (Tuffrey-Wijne et al. 2018).
Strengths
This review sheds light on an important and timely
concept. It also contributes to answering current
questions around advance care planning and
end-of-life-decision-making with people with ID
(Wagemans and Van Wijmen 2014; Voss et al. 2017;
Wagemans and van Bokhoven 2018). We
systematically searched the electronic databases in
collaboration with a biomedical information
specialist. Thereby, two researchers (HN and IK)
independently screened all abstracts for inclusion.
Another strength is that we followed the PRISMA
Scoping Review Guidelines (Tricco et al. 2018),
which ensured complete and transparent reporting of
our scoping review. The use of van de Pol’s SDM
model as a framework ensured that we used an
inclusive conceptualisation of SDM.
Gaps and deficiencies
All studies were conducted in high-income countries,
with a high proportion of Dutch studies (n ¼ 8). This
limits the generalisability of the combined study
results; because of differences in healthcare systems
and cultures, it is unknown to what extent the results
of this review can be generalised to other countries.
The legislation around capacity and decision-making
varies across countries. In addition, most people with
ID received residential care, the number of
participants was limited in most studies and there was
generally little variation in the level of ID.
Furthermore, the last phase of life was not clearly
defined in the included studies, and its interpretation
may therefore differ per study. In addition, none of
the studies found included a definition of SDM.
These results are indicative of decision-making in the
palliative care context being still in its infancy.
Conclusion
People with ID do not often actively participate in
decision-making processes in their last phase of life,
and their opinion about not being involved is unclear.
Although it is emphasised in the literature that people
with ID should be involved in decision-making in the
last phase of life, a uniform best practice about what
this should look like is lacking. On the basis of the
results, we recommend developing an aid that
specifically supports systematically taking preferences
of people with ID in the last phase of life into account.
As indicated in the literature, even if a person is not
able to actually participate in the decision-making
process, decisions can be aligned to the values and
preferences of a person with ID (Watson et al. 2017).
This can be achieved by involving the inner circle
around the person with ID and by looking at the life
history and earlier medical experiences of the person
with ID. To make good decisions, professionals and
relatives should be attentive to the expression and
signals of needs and distress a person with ID is
giving. A good relationship between relatives and
professionals is essential to ensure good end-of-life
care in the best interest of the person with ID. Further
research should be conducted to investigate what role
people with ID see for themselves in SDM around
end-of-life decision-making in the last phase of life.
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Table A1 Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) Checklist
Section Item PRISMA-ScR checklist item
Reported
on page #
Title
Title 1 Identify the report as a scoping review. 1
Abstract
Structured summary 2 Provide a structured summary that includes (as applicable): background,
objectives, eligibility criteria, sources of evidence, charting methods, results
and conclusions that relate to the review questions and objectives.
1
Introduction
Rationale 3 Describe the rationale for the review in the context of what is already known.
Explain why the review questions/objectives lend themselves to a scoping
review approach.
3
Objectives 4 Provide an explicit statement of the questions and objectives being addressed
with reference to their key elements (e.g. population or participants,
concepts and context) or other relevant key elements used to conceptualise
the review questions and/or objectives.
2
Methods
Protocol and registration 5 Indicate whether a review protocol exists; state if and where it can be accessed
(e.g. a Web address); and if available, provide registration information, including
the registration number.
–
Eligibility criteria 6 Specify characteristics of the sources of evidence used as eligibility criteria (e.g.
years considered, language and publication status), and provide a rationale.
3
Information sources† 7 Describe all information sources in the search (e.g., databases with dates of
coverage and contact with authors to identify additional sources), as well as
the date the most recent search was executed.
3
Search 8 Present the full electronic search strategy for at least 1 database, including any
limits used, such that it could be repeated.
Box 2
Selection of sources of
evidence‡
9 State the process for selecting sources of evidence (i.e. screening and eligibility)
included in the scoping review.
3, 4
Data charting process§ 10 Describe the methods of charting data from the included sources of evidence
(e.g. calibrated forms or forms that have been tested by the team before
their use, and whether data charting was done independently or in duplicate)
and any processes for obtaining and confirming data from investigators.
4
Data items 11 List and define all variables for which data were sought and any assumptions and
simplifications made.
3
Critical appraisal of individual
sources of evidence¶
12 If done, provide a rationale for conducting a critical appraisal of included
sources of evidence; describe the methods used and how this information
was used in any data synthesis (if appropriate).
12
Synthesis of results 13 Describe the methods of handling and summarising the data that were charted. 4
Results
Selection of sources of
evidence
14 Give numbers of sources of evidence screened, assessed for eligibility, and
included in the review, with reasons for exclusions at each stage, ideally using
a flow diagram.
4
Characteristics of sources of
evidence
15 For each source of evidence, present characteristics for which data were
charted and provide the citations.
4,5
Critical appraisal within
sources of evidence
16 If done, present data on critical appraisal of included sources of evidence (see
item 12).
12
Results of individual sources of
evidence
17 For each included source of evidence, present the relevant data that were
charted that relate to the review questions and objectives.
Table 1
Synthesis of results 18 4–9
Journal of Intellectual Disability Research
H. W. Noorlandt et al. • Shared decision-making with people with ID
© 2020 The Authors. Journal of Intellectual Disability Research published by MENCAP and International Association of the
Scientific Study of Intellectual and Developmental Disabilities and John Wiley & Sons Ltd
Accepted 18 August 2020
16
Table A1. (Continued)
Section Item PRISMA-ScR checklist item
Reported
on page #
Summarise and/or present the charting results as they relate to the review
questions and objectives.
Discussion
Summary of evidence 19 Summarise the main results (including an overview of concepts, themes, and
types of evidence available), link to the review questions and objectives, and
consider the relevance to key groups.
9,10
Limitations 20 Discuss the limitations of the scoping review process. 11, 12
Conclusions 21 Provide a general interpretation of the results with respect to the review
questions and objectives, as well as potential implications and/or next steps.
10,11,12
Funding
Funding 22 Describe sources of funding for the included sources of evidence, as well as
sources of funding for the scoping review. Describe the role of the funders
of the scoping review.
Title page
From: Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMAScR): Checklist and
Explanation. Ann Intern Med. 2018; 169:467–473. doi: 10.7326/M18-0850.
JBI, Joanna Briggs Institute; PRISMA-ScR, Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews.
†Where sources of evidence (see second footnote) are compiled from, such as bibliographic databases, social media platforms, and Web sites.
‡
A more inclusive/heterogeneous term used to account for the different types of evidence or data sources (e.g. quantitative and/or qualitative research,
expert opinion and policy documents) that may be eligible in a scoping review as opposed to only studies. This is not to be confused with information
sources (first footnote).
§
The frameworks by Arksey and O’Malley (6) and Levac and colleagues (7) and the JBI guidance (4, 5) refer to the process of data extraction in a scoping
review as data charting.
¶The process of systematically examining research evidence to assess its validity, results and relevance before using it to inform a decision. This term is used
for items 12 and 19 instead of ‘risk of bias’ (which is more applicable to systematic reviews of interventions) to include and acknowledge the various
sources of evidence that may be used in a scoping review (e.g. quantitative and/or qualitative research, expert opinion and policy document).
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